News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current LLY market cap is 750.47B. The company's latest EPS is USD 11.1740 and P/E is 70.97.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 8.77B | 11.3B | 11.44B | 13.53B | 12.73B |
| Operating Income | 2.51B | 4.15B | 1.61B | 5.06B | 3.73B |
| Net Income | 2.24B | 2.97B | 970.3M | 4.41B | 2.76B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 24.56B | 28.32B | 28.54B | 34.12B | 45.04B |
| Operating Income | 6.06B | 6.66B | 7.37B | 6.46B | 13.32B |
| Net Income | 6.19B | 5.58B | 6.24B | 5.24B | 10.59B |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 63.94B | 71.87B | 75.61B | 78.71B | 89.39B |
| Total Liabilities | 51.05B | 58.24B | 61.29B | 64.44B | 73.54B |
| Total Equity | 12.9B | 13.64B | 14.32B | 14.27B | 15.85B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 46.63B | 48.81B | 49.49B | 64.01B | 78.71B |
| Total Liabilities | 40.81B | 39.65B | 38.71B | 53.14B | 64.44B |
| Total Equity | 5.83B | 9.15B | 10.78B | 10.86B | 14.27B |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.17B | 2.63B | 6.34B | 8.82B | 1.67B |
| Investing | -1.18B | -3.38B | -7.38B | -9.3B | -3.35B |
| Financing | -311.3M | 1.24B | 1.46B | 1.23B | 1.38B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 6.5B | 7.26B | 7.08B | 4.24B | 8.82B |
| Investing | -2.26B | -2.76B | -3.26B | -7.15B | -9.3B |
| Financing | -3.14B | -4.13B | -5.41B | 3.5B | 1.23B |
| Market Cap | 750.47B |
| Price to Earnings Ratio | 70.97 |
| Price to Sales Ratio | 16.69 |
| Price to Cash Ratio | 229.95 |
| Price to Book Ratio | 52.66 |
| Dividend Yield | 0.76% |
| Shares Outstanding | 947.74M |
| Average Volume (1 week) | 2.93M |
| Average Volume (1 Month) | 3.05M |
| 52 Week Change | -15.31% |
| 52 Week High | 972.53 |
| 52 Week Low | 677.0912 |
| Spread (Intraday) | 1.96 (0.25%) |
| Company Name | Eli Lilly and Co |
| Address |
334 north senate avenue indianapolis, indiana 46204 |
| Website | https://www.lilly.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
